文献速递冠心病心力衰竭与心肌病

微轴流泵对STEMI相关心源性休克血流动力学的影响

Effect of Microaxial Flow Pump on Hemodynamics in STEMI-Related Cardiogenic Shock.
PubMed 文献 · J Am Coll Cardiol · 2025-01-01

该研究为DanGer休克试验亚组分析,纳入223例STEMI-CS患者,其中mAFP组125例、标准治疗组98例,使用肺动脉导管监测48小时血流动力学。结果显示mAFP组平均肺动脉压和PCWP更低,CPO更高,12小时后CO持续高于标准治疗组,提示mAFP降低心脏固有机械做功。

要点

  • mAFP组平均肺动脉压和PCWP在48小时内持续低于标准治疗组。
  • mAFP组CPO初始及48小时内均高于标准治疗组。
  • mAFP组CO在12小时后持续高于标准治疗组。

核心结论

  • mAFP通过降低自身心输出量、肺动脉压和左室充盈压,同时维持心脏和mAFP向机体输送的液压功率输出(CPO),减少STEMI-CS患者心脏固有机械做功。

研究设计与样本

  • DanGer休克试验的亚组分析,将STEMI-CS患者随机分配至mAFP或标准治疗,使用肺动脉导管监测前48小时血流动力学。
  • 324例入住CICU的患者中223例(68%)有血流动力学监测数据,标准治疗组98例(63%),mAFP组125例(74%)。

主要发现

  • CICU入住后首次测得CO中位数:标准治疗组3.4 L/min(Q1-Q3: 2.6-4.4 L/min),mAFP组3.7 L/min(Q1-Q3: 3.2-4.5 L/min),P=0.13。
  • 6小时后CO在mAFP组增加,且从12小时至48小时持续高于标准治疗组。
  • 首次测得平均肺动脉压中位数:标准治疗组31 mm Hg(Q1-Q3: 29-39 mm Hg),mAFP组27 mm Hg(Q1-Q3: 23-33 mm Hg),P<0.001,且mAFP组在所有时间点均更低。
  • 首次测得PCWP中位数:mAFP组18 mm Hg(Q1-Q3: 14-22 mm Hg)低于标准治疗组22 mm Hg(Q1-Q3: 20-26 mm Hg),P<0.001,且直至48小时持续更低。
  • 首次测得CPO中位数:标准治疗组0.56 W(95%CI: 0.41-0.76 W),mAFP组0.68 W(95%CI: 0.51-0.85 W),P=0.01,且mAFP组直至48小时持续更高。

临床怎么用

  • 对于STEMI-CS患者,mAFP可降低肺动脉压和左室充盈压,同时维持CPO,提示其具有卸载左室作用。

局限性

  • 本研究为DanGer休克试验的亚组分析,仅223例(68%)患者有血流动力学监测数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The microaxial flow pump (mAFP) improves survival in selected patients with ST-segment elevation myocardial infarction-induced cardiogenic shock (STEMI-CS). Understanding the impact on cardiac output (CO), cardiac power output (CPO), and pulmonary artery pressure (PAP) provides insight into the potential unloading effect of the device, which is a reduction in total intrinsic mechanical work of the heart. OBJECTIVE: This study sought to determine the effect of mAFP on hemodynamics in STEMI-CS. METHODS: This substudy of the DanGer (Danish-German) shock trial randomized patients with STEMI-CS to mAFP or standard of care. Patients were monitored using a pulmonary artery catheter. Outcome measures were CO, CPO, and mean PAP during the first 48 hours. RESULTS: Of 324 patients admitted to the cardiac intensive care unit (CICU), 223 patients (68%) had data on hemodynamic monitoring: 98 patients (63%) in the standard of care, and 125 (74%) patients in the mAFP group. The median first measured CO after CICU admission was 3.4 L/min (Q1-Q3: 2.6-4.4 L/min) in the control vs 3.7 L/min (Q1-Q3: 3.2-4.5 L/min) in the mAFP group; P = 0.13. After 6 hours, the CO increased in and was consistently higher in the mAFP group from 12 hours until 48 hours. The first measured mean PAP in the CICU had a median value of 31 mm Hg (Q1-Q3: 29-39 mm Hg) in the standard of care group compared with 27 mm Hg (Q1-Q3: 23-33 mm Hg) in the mAFP group (P < 0.001) and remained lower at all time points in the mAFP. Also, the first measured PCWP was lower in mAFP vs standard of care (18 mm Hg [Q1-Q3: 14-22 mm Hg] vs 22 mm Hg [Q1-Q3: 20-26 mm Hg]; P < 0.001) and remained lower until 48 hours. The median first measured CPO was 0.56 W (95% CI: 0.41-0.76 W) in the control vs 0.68 W (95% CI: 0.51-0.85 W; P = 0.01), in the mAFP group, and remained higher in the mAFP group until 48 hours. CONCLUSIONS: The mAFP reduces intrinsic mechanical work of the heart in STEMI-CS patients enrolled in the DanGer shock trial by reducing native CO, pulmonary pressures, and LV filling pressures while maintaining hydraulic power output delivered to the body by the heart and mAFP (CPO). (Danish Cardiogenic Shock Trial [DanShock]; NCT01633502).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Møller, Beske, Jensen, et al. Effect of Microaxial Flow Pump on Hemodynamics in STEMI-Related Cardiogenic Shock. J Am Coll Cardiol. 2025. PMID: 40562510. doi:10.1016/j.jacc.2025.04.062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。